Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.31 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8043079 | 0.82 | TSHR (0.54) | TSHRSMN1; SMN2ALDH1A1DNM1 | |
| SCHEMBL3638966 | 0.82 | TSHR (0.43) | TSHRSMN1; SMN2ALDH1A1DNM1 | |
| SCHEMBL11648923 | 0.79 | TSHR (0.39) | TSHRSMN1; SMN2ALDH1A1DNM1 | |
| SCHEMBL1883787 | 0.78 | TSHR (0.61) | TSHRSMN1; SMN2ALDH1A1DNM1PLA2G2C | |
| SCHEMBL3803410 | 0.77 | TSHR (0.42) | TSHRSMN1; SMN2DNM1 | |
| SCHEMBL11664850 | 0.77 | TSHR (0.42) | TSHRSMN1; SMN2DNM1 | |
| SCHEMBL9717978 | 0.77 | TSHR (0.39) | TSHRSMN1; SMN2ALDH1A1DNM1 | |
| SCHEMBL9717975 | 0.77 | TSHR (0.39) | TSHRSMN1; SMN2ALDH1A1DNM1 | |
| SCHEMBL16030557 | 0.76 | TSHR (0.46) | TSHRSMN1; SMN2ALDH1A1DNM1 | |
| SCHEMBL8676005 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3621955-B1 | DEGRADABLE IMIDAZOLIUM OLIGOMER AND POLYMER FOR ANTIMICROBIAL APPLICATIONS | AGENCY SCIENCE TECH & RES (SG) | 2021-07-14 | — | — | EP | claimed |
| US-10927100-B2 | Degradable imidazolium oligomer and polymer for antimicrobial applications | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-02-23 | — | — | US | claimed |
| US-20200181122-A1 | Degradable Imidazolium Oligomer and Polymer for Antimicrobial Applications | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-06-11 | — | — | US | claimed |
| EP-3621955-A1 | DEGRADABLE IMIDAZOLIUM OLIGOMER AND POLYMER FOR ANTIMICROBIAL APPLICATIONS | Agency for Science, Technology and Research (SG) | 2020-03-18 | — | — | EP | claimed |
| US-10562977-B2 | Ligand-cytotoxic drug conjugate, preparation method thereof, and uses thereof | SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) | 2020-02-18 | — | — | US | claimed |
| CN-110799500-A | Degradable imidazolium oligomers and polymers for antimicrobial applications | 新加坡科技研究局 | 2020-02-14 | — | — | CN | claimed |
| WO-2019004940-A1 | DEGRADABLE IMIDAZOLIUM OLIGOMER AND POLYMER FOR ANTIMICROBIAL APPLICATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-01-03 | — | — | WO | claimed |
| CN-107099016-A | Trigger response chain fragmentation polymer | 伊利诺伊大学董事会 | 2017-08-29 | — | — | CN | claimed |
| US-20170002090-A1 | LIGAND-CYTOTOXIC DRUG CONJUGATE, PREPARATION METHOD THEREOF, AND USES THEREOF | SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) | 2017-01-05 | — | — | US | claimed |
| EP-3100731-A1 | LIGAND-CYTOTOXICITY DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND USES THEREOF | Shanghai Hengrui Pharmaceutical Co., Ltd. (CN) | 2016-12-07 | — | — | EP | claimed |
| WO-2001085694-A2 | SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2001-11-15 | — | — | WO | claimed |
| EP-0915928-A4 | SCORCH RESISTANT ADDITIVES FOR POLYURETHANE FOAMS | CROMPTON CORP (US) | 2001-08-29 | — | — | EP | claimed |
| US-6051620-A | PROCESS FOR PRODUCING A POLYURETHANE FOAM BY REACTING A POLYISOCYANATE, POLYOL AND WATER; WHEREIN AT LEAST A PORTION OF THE POLYOL COMPRISES A POLYOL CONTAINING ESTER LINKAGES AND HYDRAZIDE LINKAGES; NONDISCOLORING | CK WITCO CORPORATION | 2000-04-18 | — | — | US | claimed |
| EP-0915928-A1 | SCORCH RESISTANT ADDITIVES FOR POLYURETHANE FOAMS | WITCO CORPORATION (US) | 1999-05-19 | — | — | EP | claimed |
| WO-1998056849-A1 | SCORCH RESISTANT ADDITIVES FOR POLYURETHANE FOAMS | WITCO CORPORATION (US) | 1998-12-17 | — | — | WO | claimed |
| EP-0247482-B1 | HARDENED REAGENT COATINGS, AND PROCESSES FOR THE PREPARATION THEREOF | MILES INC. (US) | 1992-04-22 | — | — | EP | claimed |
| EP-0247482-A2 | Hardened reagent coatings, and processes for the preparation thereof | MILES INC. (US) | 1987-12-02 | — | — | EP | claimed |
| US-4303752-A | RELEASING AATP WITH SURFACTANTS WITHOUT LYSING CELL MEMBRANE OR WALL | MINNESOTA MINING AND MANUFACTURING COMPANY, A CORP OF DE. | 1981-12-01 | — | — | US | claimed |
| US-4233398-A | Process for the hardening of photographic layers utilizing fast acting hardener and polysaccharide | AGFA-GEVAERT, A.G. (DE) | 1980-11-11 | — | — | US | claimed |
| US-4119464-A | PRE-HARDENER OF COMPLEX-FORMING SALT OF ALUMINUM, CHROMIUM, OR ZIRCONIUM | AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) | 1978-10-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10927100-B2 | Degradable imidazolium oligomer and polymer for antimicrobial applications | NOD2, CFTR, PUF60 | TSHR 4188/4885SMN1; SMN2 2413/4885ALDH1A1 3361/4885 |
| US-20200181122-A1 | Degradable Imidazolium Oligomer and Polymer for Antimicrobial Applications | NOD2, CFTR, PUF60 | TSHR 4188/4885SMN1; SMN2 2413/4885ALDH1A1 3361/4885 |
| US-10562977-B2 | Ligand-cytotoxic drug conjugate, preparation method thereof, and uses thereof | LPXN, ADGRF1, LHCGR | TSHR 609/4885SMN1; SMN2 4099/4885ALDH1A1 3429/4885 |
| US-20170002090-A1 | LIGAND-CYTOTOXIC DRUG CONJUGATE, PREPARATION METHOD THEREOF, AND USES THEREOF | LPXN, ADGRF1, LHCGR | TSHR 609/4885SMN1; SMN2 4099/4885ALDH1A1 3429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.